▶ 調査レポート

世界の進行性多巣性白質脳症治療市場：市場規模・現状・予測
• 英文タイトル：Global Progressive Multifocal Leukoencephalopathy Treatment Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の進行性多巣性白質脳症治療市場：市場規模・現状・予測 / Global Progressive Multifocal Leukoencephalopathy Treatment Market Size, Status and Forecast 2019-2025 / QYR9N7888資料のイメージです。• レポートコード：QYR9N7888
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、進行性多巣性白質脳症治療のグローバル市場について調査・分析したレポートで、種類別（抗レトロウイルス療法、抗ウイルス/抗JCV、その他の症状）、用途別（病院薬局、ドラッグストア、小売薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・進行性多巣性白質脳症治療の世界市場規模
・主要企業別市場シェア
・進行性多巣性白質脳症治療の世界市場規模：種類別（抗レトロウイルス療法、抗ウイルス/抗JCV、その他の症状）
・進行性多巣性白質脳症治療の世界市場規模：用途別（病院薬局、ドラッグストア、小売薬局）
・進行性多巣性白質脳症治療のアメリカ市場規模（種類別、用途別）
・進行性多巣性白質脳症治療のヨーロッパ市場規模（種類別、用途別）
・進行性多巣性白質脳症治療の中国市場規模（種類別、用途別）
・進行性多巣性白質脳症治療の日本市場規模（種類別、用途別）
・進行性多巣性白質脳症治療の東南アジア市場規模（種類別、用途別）
・進行性多巣性白質脳症治療のインド市場規模（種類別、用途別）
・進行性多巣性白質脳症治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・進行性多巣性白質脳症治療の世界市場予測（2019年-2025年）
・進行性多巣性白質脳症治療の地域別市場予測（2019年-2025年）
...

Progressive multifocal leukoencephalopathy is a rare but debilitating and frequently fatal viral disease of the central nervous system, primarily affecting individuals with chronically and severely suppressed immune systems.Growing prevalence of HIV is expected to drive the growth of the progressive multifocal leukoencephalopathy treatment market.
In 2018, the global Progressive Multifocal Leukoencephalopathy Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Progressive Multifocal Leukoencephalopathy Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Progressive Multifocal Leukoencephalopathy Treatment development in United States, Europe and China.

The key players covered in this study
Pfizer
Roche
Gilead Sciences
GlaxoSmithKline
Sanofi
Allergan
Novartis
Mylan
AbbVie
Bristol-Myers Squibb

Market segment by Type, the product can be split into
Anti-Retroviral Therapy
Antiviral/Anti JCV
Other Symptomatic

Market segment by Application, split into
Hospital Pharmacies
Drug Stores
Retail Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Progressive Multifocal Leukoencephalopathy Treatment status, future forecast, growth opportunity, key market and key players.
To present the Progressive Multifocal Leukoencephalopathy Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Progressive Multifocal Leukoencephalopathy Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Progressive Multifocal Leukoencephalopathy Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Anti-Retroviral Therapy
1.4.3 Antiviral/Anti JCV
1.4.4 Other Symptomatic
1.5 Market by Application
1.5.1 Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Drug Stores
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Progressive Multifocal Leukoencephalopathy Treatment Market Size
2.2 Progressive Multifocal Leukoencephalopathy Treatment Growth Trends by Regions
2.2.1 Progressive Multifocal Leukoencephalopathy Treatment Market Size by Regions (2014-2025)
2.2.2 Progressive Multifocal Leukoencephalopathy Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Progressive Multifocal Leukoencephalopathy Treatment Market Size by Manufacturers
3.1.1 Global Progressive Multifocal Leukoencephalopathy Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Progressive Multifocal Leukoencephalopathy Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Progressive Multifocal Leukoencephalopathy Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Progressive Multifocal Leukoencephalopathy Treatment Key Players Head office and Area Served
3.3 Key Players Progressive Multifocal Leukoencephalopathy Treatment Product/Solution/Service
3.4 Date of Enter into Progressive Multifocal Leukoencephalopathy Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2014-2019)
4.2 Global Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Progressive Multifocal Leukoencephalopathy Treatment Market Size (2014-2019)
5.2 Progressive Multifocal Leukoencephalopathy Treatment Key Players in United States
5.3 United States Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type
5.4 United States Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application

6 Europe
6.1 Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size (2014-2019)
6.2 Progressive Multifocal Leukoencephalopathy Treatment Key Players in Europe
6.3 Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type
6.4 Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application

7 China
7.1 China Progressive Multifocal Leukoencephalopathy Treatment Market Size (2014-2019)
7.2 Progressive Multifocal Leukoencephalopathy Treatment Key Players in China
7.3 China Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type
7.4 China Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application

8 Japan
8.1 Japan Progressive Multifocal Leukoencephalopathy Treatment Market Size (2014-2019)
8.2 Progressive Multifocal Leukoencephalopathy Treatment Key Players in Japan
8.3 Japan Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type
8.4 Japan Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Progressive Multifocal Leukoencephalopathy Treatment Market Size (2014-2019)
9.2 Progressive Multifocal Leukoencephalopathy Treatment Key Players in Southeast Asia
9.3 Southeast Asia Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type
9.4 Southeast Asia Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application

10 India
10.1 India Progressive Multifocal Leukoencephalopathy Treatment Market Size (2014-2019)
10.2 Progressive Multifocal Leukoencephalopathy Treatment Key Players in India
10.3 India Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type
10.4 India Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Progressive Multifocal Leukoencephalopathy Treatment Market Size (2014-2019)
11.2 Progressive Multifocal Leukoencephalopathy Treatment Key Players in Central & South America
11.3 Central & South America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type
11.4 Central & South America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Progressive Multifocal Leukoencephalopathy Treatment Introduction
12.1.4 Pfizer Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Progressive Multifocal Leukoencephalopathy Treatment Introduction
12.2.4 Roche Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)
12.2.5 Roche Recent Development
12.3 Gilead Sciences
12.3.1 Gilead Sciences Company Details
12.3.2 Company Description and Business Overview
12.3.3 Progressive Multifocal Leukoencephalopathy Treatment Introduction
12.3.4 Gilead Sciences Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)
12.3.5 Gilead Sciences Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Company Details
12.4.2 Company Description and Business Overview
12.4.3 Progressive Multifocal Leukoencephalopathy Treatment Introduction
12.4.4 GlaxoSmithKline Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)
12.4.5 GlaxoSmithKline Recent Development
12.5 Sanofi
12.5.1 Sanofi Company Details
12.5.2 Company Description and Business Overview
12.5.3 Progressive Multifocal Leukoencephalopathy Treatment Introduction
12.5.4 Sanofi Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)
12.5.5 Sanofi Recent Development
12.6 Allergan
12.6.1 Allergan Company Details
12.6.2 Company Description and Business Overview
12.6.3 Progressive Multifocal Leukoencephalopathy Treatment Introduction
12.6.4 Allergan Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)
12.6.5 Allergan Recent Development
12.7 Novartis
12.7.1 Novartis Company Details
12.7.2 Company Description and Business Overview
12.7.3 Progressive Multifocal Leukoencephalopathy Treatment Introduction
12.7.4 Novartis Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)
12.7.5 Novartis Recent Development
12.8 Mylan
12.8.1 Mylan Company Details
12.8.2 Company Description and Business Overview
12.8.3 Progressive Multifocal Leukoencephalopathy Treatment Introduction
12.8.4 Mylan Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)
12.8.5 Mylan Recent Development
12.9 AbbVie
12.9.1 AbbVie Company Details
12.9.2 Company Description and Business Overview
12.9.3 Progressive Multifocal Leukoencephalopathy Treatment Introduction
12.9.4 AbbVie Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)
12.9.5 AbbVie Recent Development
12.10 Bristol-Myers Squibb
12.10.1 Bristol-Myers Squibb Company Details
12.10.2 Company Description and Business Overview
12.10.3 Progressive Multifocal Leukoencephalopathy Treatment Introduction
12.10.4 Bristol-Myers Squibb Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)
12.10.5 Bristol-Myers Squibb Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Progressive Multifocal Leukoencephalopathy Treatment Key Market Segments
Table Key Players Progressive Multifocal Leukoencephalopathy Treatment Covered
Table Global Progressive Multifocal Leukoencephalopathy Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Progressive Multifocal Leukoencephalopathy Treatment Market Size Market Share by Type 2014-2025
Figure Anti-Retroviral Therapy Figures
Table Key Players of Anti-Retroviral Therapy
Figure Antiviral/Anti JCV Figures
Table Key Players of Antiviral/Anti JCV
Figure Other Symptomatic Figures
Table Key Players of Other Symptomatic
Table Global Progressive Multifocal Leukoencephalopathy Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Drug Stores Case Studies
Figure Retail Pharmacies Case Studies
Figure Progressive Multifocal Leukoencephalopathy Treatment Report Years Considered
Table Global Progressive Multifocal Leukoencephalopathy Treatment Market Size 2014-2025 (Million US$)
Figure Global Progressive Multifocal Leukoencephalopathy Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Progressive Multifocal Leukoencephalopathy Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Progressive Multifocal Leukoencephalopathy Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Regions 2014-2019
Figure Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Regions 2014-2019
Figure Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Progressive Multifocal Leukoencephalopathy Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Manufacturers (2014-2019)
Figure Global Progressive Multifocal Leukoencephalopathy Treatment Market Share by Manufacturers in 2018
Table Global Progressive Multifocal Leukoencephalopathy Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Progressive Multifocal Leukoencephalopathy Treatment Product/Solution/Service
Table Date of Enter into Progressive Multifocal Leukoencephalopathy Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Progressive Multifocal Leukoencephalopathy Treatment Market Size Share by Type (2014-2019)
Figure Global Progressive Multifocal Leukoencephalopathy Treatment Market Size Market Share by Type (2014-2019)
Table Global Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Progressive Multifocal Leukoencephalopathy Treatment Market Size Share by Application (2014-2019)
Figure Global Progressive Multifocal Leukoencephalopathy Treatment Market Size Market Share by Application (2014-2019)
Figure Global Progressive Multifocal Leukoencephalopathy Treatment Revenue Market Share by Application in 2018
Figure United States Progressive Multifocal Leukoencephalopathy Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Progressive Multifocal Leukoencephalopathy Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Progressive Multifocal Leukoencephalopathy Treatment Market Share (2018-2019)
Table United States Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Progressive Multifocal Leukoencephalopathy Treatment Market Share by Type (2014-2019)
Table United States Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application (2014-2019)
Figure Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Progressive Multifocal Leukoencephalopathy Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Progressive Multifocal Leukoencephalopathy Treatment Market Share (2018-2019)
Table Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Progressive Multifocal Leukoencephalopathy Treatment Market Share by Type (2014-2019)
Table Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application (2014-2019)
Figure China Progressive Multifocal Leukoencephalopathy Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Progressive Multifocal Leukoencephalopathy Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Progressive Multifocal Leukoencephalopathy Treatment Market Share (2018-2019)
Table China Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2014-20189) (Million US$)
Table China Progressive Multifocal Leukoencephalopathy Treatment Market Share by Type (2014-2019)
Table China Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table China Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application (2014-2019)
Figure Japan Progressive Multifocal Leukoencephalopathy Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Progressive Multifocal Leukoencephalopathy Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Progressive Multifocal Leukoencephalopathy Treatment Market Share (2018-2019)
Table Japan Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Progressive Multifocal Leukoencephalopathy Treatment Market Share by Type (2014-2019)
Table Japan Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Progressive Multifocal Leukoencephalopathy Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Progressive Multifocal Leukoencephalopathy Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Progressive Multifocal Leukoencephalopathy Treatment Market Share (2018-2019)
Table Southeast Asia Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Progressive Multifocal Leukoencephalopathy Treatment Market Share by Type (2014-2019)
Table Southeast Asia Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application (2014-2019)
Figure India Progressive Multifocal Leukoencephalopathy Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Progressive Multifocal Leukoencephalopathy Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Progressive Multifocal Leukoencephalopathy Treatment Market Share (2018-2019)
Table India Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2014-2019) (Million US$)
Table India Progressive Multifocal Leukoencephalopathy Treatment Market Share by Type (2014-2019)
Table India Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table India Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application (2014-2019)
Figure Central & South America Progressive Multifocal Leukoencephalopathy Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Progressive Multifocal Leukoencephalopathy Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Progressive Multifocal Leukoencephalopathy Treatment Market Share (2018-2019)
Table Central & South America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Progressive Multifocal Leukoencephalopathy Treatment Market Share by Type (2014-2019)
Table Central & South America Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Progressive Multifocal Leukoencephalopathy Treatment Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Roche Company Details
Table Roche Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)
Table Roche Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)(Million US$)
Figure Gilead Sciences Revenue Growth Rate in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)
Table Gilead Sciences Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)
Table Sanofi Recent Development
Table Allergan Company Details
Table Allergan Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)
Table Allergan Recent Development
Table Novartis Company Details
Table Novartis Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)
Table Novartis Recent Development
Table Mylan Company Details
Table Mylan Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)(Million US$)
Figure Mylan Revenue Growth Rate in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)
Table Mylan Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)
Table AbbVie Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Progressive Multifocal Leukoencephalopathy Treatment Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Global Progressive Multifocal Leukoencephalopathy Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Progressive Multifocal Leukoencephalopathy Treatment Market Size Share by Regions (2019-2025)
Figure Global Progressive Multifocal Leukoencephalopathy Treatment Market Size Share by Regions in 2025
Figure United States Progressive Multifocal Leukoencephalopathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Progressive Multifocal Leukoencephalopathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Progressive Multifocal Leukoencephalopathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Progressive Multifocal Leukoencephalopathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Progressive Multifocal Leukoencephalopathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Progressive Multifocal Leukoencephalopathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Progressive Multifocal Leukoencephalopathy Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Progressive Multifocal Leukoencephalopathy Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Progressive Multifocal Leukoencephalopathy Treatment Market Size by Product (2019-2025)
Figure Global Progressive Multifocal Leukoencephalopathy Treatment Market Size by Product in 2025
Table Global Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application (2019-2025)
Figure Global Progressive Multifocal Leukoencephalopathy Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の進行性再発性多発性硬化症治療市場2019
    Global Progressive Relapsing Multiple Sclerosis Treatment Sales Market Report 2019
    QYR9N3775 2019年6月13日 106Pages
    本調査レポートでは、進行性再発性多発性硬化症治療の世界市場について調査・分析し、進行性再発性多発性硬化症治療のメーカー別販売量、市場シェア分析、種類別販売分析（COG-133、GZ-402668、イネビリズマブ、VCE-0032、その他）、用途別販売分析（診療所、Hopital、その他）、地域別販売...
  • 世界の一次進行型多発性硬化症の治療市場2019
    Global Primary Progressive Multiple Sclerosis Treatment Sales Market Report 2019
    QYR9N3747 2019年6月13日 107Pages
    本調査レポートでは、一次進行型多発性硬化症の治療の世界市場について調査・分析し、一次進行型多発性硬化症の治療のメーカー別販売量、市場シェア分析、種類別販売分析（ApE、ビオチン、GZ-402668、イブジラスト、イデベノン、その他）、用途別販売分析（病院、診療所、その他）、地域別販売分析（米国、ヨー...
  • 世界の髄膜炎菌感染症の治療市場：市場規模・現状・予測
    Global Meningococcal Infections Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7541 2019年6月14日 94Pages
    当資料は、髄膜炎菌感染症の治療のグローバル市場について調査・分析したレポートで、種類別（抗生物質、グルココルチコイド、プロテインC濃縮物）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています...
  • 世界の腱炎治療市場：市場規模・現状・予測
    Global Tendinitis Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8111 2019年6月14日 93Pages
    当資料は、腱炎治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・腱炎治療...
  • 世界のフォンヴィレブランド病治療市場：市場規模・現状・予測
    Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8188 2019年6月14日 93Pages
    当資料は、フォンヴィレブランド病治療のグローバル市場について調査・分析したレポートで、種類別（ヴェイヴォンディ、フミン酸-P、英数字、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...
  • 世界のディンプル形成術の治療市場：市場規模・現状・予測
    Global Dimpleplasty Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7109 2019年6月14日 93Pages
    当資料は、ディンプル形成術の治療のグローバル市場について調査・分析したレポートで、種類別（光線療法、レーザー治療、その他）、用途別（病院、皮膚科クリニック、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の汗腺炎掻爬治療市場：市場規模・現状・予測
    Global Hidradenitis Suppurativa Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7295 2019年6月14日 99Pages
    当資料は、汗腺炎掻爬治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・汗腺炎...
  • 世界の多発性骨髄腫の治療市場：市場規模・現状・予測
    Global Multiple Myeloma Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7601 2019年6月14日 94Pages
    当資料は、多発性骨髄腫の治療のグローバル市場について調査・分析したレポートで、種類別（プロテアソーム阻害剤、免疫調節剤（IMiD）、ヒストンデアセチラーゼ（HDAC）阻害剤、免疫療法、細胞毒性化学療法）、用途別（病院、診療所、がん治療とリハビリセンター）、主要地域別（アメリカ、ヨーロッパ、中国、日本...
  • 世界の精神神経疾患および治療市場：市場規模・現状・予測
    Global Neuropsychiatric Disorders And Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7660 2019年6月14日 97Pages
    当資料は、精神神経疾患および治療のグローバル市場について調査・分析したレポートで、種類別（変性疾患、神経障害、精神病）、用途別（病院、診療所、研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    ...
  • 世界の副甲状腺機能低下症の治療市場：市場規模・現状・予測
    Global Hypoparathyroidism Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7330 2019年6月14日 99Pages
    当資料は、副甲状腺機能低下症の治療のグローバル市場について調査・分析したレポートで、種類別（経口、非経口）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    <...
  • 世界の進行性再発性多発性硬化症治療市場2019世界の進行性再発性多発性硬化症治療市場2019 The global Progressive Relapsing Multiple Sclerosis Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Progressive Relapsing Multiple Sclerosis Treatment market status and forecast, c…
  • 世界の一次進行型多発性硬化症の治療市場2019世界の一次進行型多発性硬化症の治療市場2019 The global Primary Progressive Multiple Sclerosis Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Primary Progressive Multiple Sclerosis Treatment market status and forecast, categ…
  • 世界の多嚢胞性卵巣症候群の治療市場：市場規模・現状・予測世界の多嚢胞性卵巣症候群の治療市場：市場規模・現状・予測 Polycystic ovary syndrome is a set of symptoms due to elevated androgens in females.Signs and symptoms of polycystic ovary syndrome nclude irregular or no menstrual periods, heavy periods, excess body and facial hair, acne, pelvic pain, difficulty getting pregnant and patches of thick, darker, velve…
  • 世界の薬物中毒治療市場：市場規模・現状・予測世界の薬物中毒治療市場：市場規模・現状・予測 Drug addiction is a complex neurobiological disease that requires integrated treatment of the mind, body, and spirit. It is considered a brain disease because drugs change the brain — they change its structure and how it works. Without treatment, these brain changes can be long-lasting. Addiction is…
  • 世界のクッシング病治療市場：市場規模・現状・予測世界のクッシング病治療市場：市場規模・現状・予測 Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…